MX2022002420A - Metodos de tratamiento de trastorno de espectro autista. - Google Patents
Metodos de tratamiento de trastorno de espectro autista.Info
- Publication number
- MX2022002420A MX2022002420A MX2022002420A MX2022002420A MX2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A MX 2022002420 A MX2022002420 A MX 2022002420A
- Authority
- MX
- Mexico
- Prior art keywords
- vafidemstat
- autism spectrum
- spectrum disorders
- treating autism
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Se proporcionan en la presente métodos para tratar trastorno de espectro autista usando vafidemstat.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19382751 | 2019-09-03 | ||
EP19382855 | 2019-10-03 | ||
PCT/EP2020/074602 WO2021043905A1 (en) | 2019-09-03 | 2020-09-03 | Vafidemstat for use in treating autism spectrum disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022002420A true MX2022002420A (es) | 2022-05-06 |
Family
ID=72266308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022002420A MX2022002420A (es) | 2019-09-03 | 2020-09-03 | Metodos de tratamiento de trastorno de espectro autista. |
Country Status (6)
Country | Link |
---|---|
US (2) | US20220288039A1 (es) |
EP (1) | EP4025210A1 (es) |
JP (1) | JP2022546134A (es) |
CN (1) | CN114615979A (es) |
MX (1) | MX2022002420A (es) |
WO (1) | WO2021043905A1 (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
WO2012013728A1 (en) | 2010-07-29 | 2012-02-02 | Oryzon Genomics S.A. | Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
CA3071804A1 (en) * | 2017-08-03 | 2019-02-07 | Oryzon Genomics, S.A. | Methods of treating behavior alterations |
-
2020
- 2020-09-03 JP JP2022514201A patent/JP2022546134A/ja active Pending
- 2020-09-03 CN CN202080076641.9A patent/CN114615979A/zh active Pending
- 2020-09-03 MX MX2022002420A patent/MX2022002420A/es unknown
- 2020-09-03 EP EP20764121.8A patent/EP4025210A1/en active Pending
- 2020-09-03 US US17/753,406 patent/US20220288039A1/en not_active Abandoned
- 2020-09-03 WO PCT/EP2020/074602 patent/WO2021043905A1/en unknown
-
2023
- 2023-08-24 US US18/455,098 patent/US20240226069A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022546134A (ja) | 2022-11-02 |
US20220288039A1 (en) | 2022-09-15 |
WO2021043905A1 (en) | 2021-03-11 |
CN114615979A (zh) | 2022-06-10 |
EP4025210A1 (en) | 2022-07-13 |
US20240226069A1 (en) | 2024-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA193736S (en) | Skin massager | |
MX2021010193A (es) | Azepino-indoles y otros heterociclos para el tratamiento de trastornos cerebrales. | |
MY192571A (en) | Treatment installation and method for treating workpieces | |
MX2018000778A (es) | Metodos para tratar trastornos mediados por hepcidinas. | |
SG11202009371WA (en) | Methods for treating atopic dermatitis by administering an il-4r inhibitor | |
MX2020008195A (es) | Compuestos para el tratamiento del dolor. | |
AU2018337076A1 (en) | Method of treatment | |
PH12020552059A1 (en) | Dosing regimen for the treatment of pi3k related disorders | |
TN2019000210A1 (en) | Antitumoral compounds | |
EP4182805A4 (en) | DATABASE SESSIONS THAT CAN BE ATTACHED AND DETACHED | |
MX2023008193A (es) | Procedimientos para tratar el cáncer. | |
EP3773491A4 (en) | METHODS OF TREATMENT FOR APOE4 / 4-ASSOCIATED DISEASES | |
PH12019501678A1 (en) | Potassium channel modulators | |
ZA202108429B (en) | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder | |
IL286126A (en) | Formulations for the treatment of cluster symptoms associated with autism spectrum disorder | |
MX2022004910A (es) | Metodos de tratamiento de los sintomas del trastorno del espectro autista. | |
MX2022002420A (es) | Metodos de tratamiento de trastorno de espectro autista. | |
MX2021009670A (es) | Tratamiento para el cancer. | |
MX2020012964A (es) | Metodos para el tratamiento de cancer de vejiga. | |
MX2022013883A (es) | Compuestos de metiltioninio para uso en el tratamiento de covid-19. | |
MX2018015464A (es) | Uso de benzoato de litio para tratar trastornos del sistema nervioso central. | |
MX2021011256A (es) | Metodos de tratamiento del trastorno limite de la personalidad. | |
EP4043013A4 (en) | METHOD FOR TREATING AFFECTIVE DISORDERS | |
MX2021011254A (es) | Metodos de tratamiento del trastorno por deficit de atencion e hiperactividad. | |
SG11202111960PA (en) | Method for treating endometriosis-associated pain by using diaminopyrimidine compound |